OLEMA PHARMACEUTICALS INC (OLMA)

US68062P1066 - Common Stock

9.93  +0.03 (+0.3%)

After market: 9.93 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
104.96M106.99M71.49M21.53M4.32M
Research and Development
86.14M82.27M51.10M13.70M3.92M
Selling, General, and Administrative Expenses
18.82M24.71M20.39M7.82M400.00K
Operating Income
-104.96M-106.99M-71.49M-21.53M-4.32M
Interest Income/Expense
8.32M2.23M440.00K-590.00K10.00K
Other Income/Expense
-19.00K-30.00K-50.00KN/A0.00
Non Recurring Items
N/AN/AN/AN/A0.00
Income Before Taxes
-96.66M-104.79M-71.10M-22.12M-4.32M
Net Income
-96.66M-104.79M-71.10M-23.99M-4.32M
EBITDA
-104.58M-106.63M-71.33M-21.52M-4.31M
 
Per Share Data
EPS Diluted Total Ops
-2.14-2.62-1.80-0.62-0.11
Non GAAP EPS
-2.16-2.62-1.80N/AN/A
 
Statistics

All data in USD

Charts